Top Biotech Stocks To Own For 2019

Stocks powered higher on news of a trade agreement between the U.S. and Mexico. The Dow Jones Industrial Average (DJINDICES:^DJI) broke 26,000 for the first time since February, and the S&P 500 (SNPINDEX:^GSPC) closed at a record high.

Today’s stock market

Index Percentage Change Point Change

Dow 1.01% 259.29
S&P 500 0.77% 22.05

Data source: Yahoo! Finance.

Biotech stocks surged, with the iShares NASDAQ Biotechnology ETF (NASDAQ:IBB) rising 1.8%. The retail sector was weak; the SPDR S&P Retail ETF (NYSEMKT:XRT) slipped 0.7%. 

As for individual stocks, Tesla (NASDAQ:TSLA) investors largely shrugged off the announcement that it will remain a public company, and Pfizer (NYSE:PFE) presented details of a drug trial that had big implications for smaller competitors.

Image source: Getty Images.

Top Biotech Stocks To Own For 2019: InspireMD, Inc.(NSPR)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Sigma Labs, Inc. (NASDAQ: SGLB) shares rose 90.9 percent to $2.52. Sigma Labs demonstrated proof of concept for closed loop quality control during metal additive manufacturing.
    Oragenics, Inc. (NYSE: OGEN) shares surged 58.4 percent to $1.9005 after the company’s AG013 for oral mucositis in head and neck cancer patients showed favorable safety profile in mid-stage OM study.
    Dick's Sporting Goods, Inc. (NYSE: DKS) shares climbed 23.2 percent to $37.5370 after the company reported upbeat Q1 earnings and raised FY18 earnings outlook.
    Summer Infant, Inc. (NASDAQ: SUMR) rose 21.9 percent to $1.17 after announcing commitment for $60 million credit facility from Bank of America and $17.5 million term loan from Pathlight Capital.
    TapImmune, Inc. (NASDAQ: TPIV) jumped 18.8 percent to $4.87. WBB Securities upgraded TapImmune from Speculative Buy to Buy.
    Movado Group, Inc. (NYSE: MOV) gained 17.2 percent to $49.45 after the company reported better-than-expected Q1 results and raised its guidance.
    ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) jumped 16.2 percent to $7.96. BTIG Research initiated coverage on ASLAN Pharmaceuticals with a Buy rating.
    Legacy Reserves LP (NASDAQ: LGCY) rose 15.5 percent to $5.6011.
    InspireMD, Inc. (NYSE: NSPR) gained 13.3 percent to $1.36 following PR announcing sustained benefit of CGuard EPS.
    Immutep Limited (NASDAQ: IMMP) shares climbed 13.2 percent to $2.7724 after the company reported new data from its ongoing TACTI-mel Phase I trial, which evaluated the combination of eftilagimod alpha, its lead compound, with Merck & Co., Inc. (NYSE: MRK)'s Keytruda in unresectable or metastatic melanoma patients, who have had a suboptimal response or had disease progression with keytruda monotherapy..
    SpartanNash Co (NASDAQ: SPTN) rose 12.2 percent to $21.20 after the company reported upbeat earnings for its first quarter on Tuesday.
    Amtech Systems, Inc. (NASDAQ: ASYS) rose 12.1 percent to
  • [By Lisa Levin] Gainers
    Oragenics, Inc. (NYSE: OGEN) shares surged 66.67 percent to close at $2.00 on Wednesday after the company’s AG013 for oral mucositis in head and neck cancer patients showed favorable safety profile in mid-stage OM study.
    Sigma Labs, Inc. (NASDAQ: SGLB) shares jumped 49.24 percent to close at $1.97 on Wednesday. Sigma Labs demonstrated proof of concept for closed loop quality control during metal additive manufacturing.
    ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) rose 34.45 percent to close at $9.21. BTIG Research initiated coverage on ASLAN Pharmaceuticals with a Buy rating.
    Dick's Sporting Goods, Inc. (NYSE: DKS) shares rose 25.82 percent to close at $38.35 after the company reported upbeat Q1 earnings and raised FY18 earnings outlook.
    TapImmune, Inc. (NASDAQ: TPIV) rose 24.15 percent to close at $5.09. WBB Securities upgraded TapImmune from Speculative Buy to Buy.
    Legacy Reserves LP (NASDAQ: LGCY) jumped 23.3 percent to close at $5.98 on Wednesday.
    Summer Infant, Inc. (NASDAQ: SUMR) gained 22.92 percent to close at $1.18 after announcing commitment for $60 million credit facility from Bank of America and $17.5 million term loan from Pathlight Capital.
    Cloud Peak Energy Inc. (NYSE: CLD) rose 21.95 percent to close at $4.00.
    SpartanNash Co (NASDAQ: SPTN) gained 21.4 percent to close at $22.92 after the company reported upbeat earnings for its first quarter on Tuesday.
    Motus GI Holdings, Inc. (NASDAQ: MOTS) rose 17.14 percent to close at $5.40.
    Movado Group, Inc. (NYSE: MOV) gained 16.59 percent to close at $49.20 after the company reported better-than-expected Q1 results and raised its guidance.
    Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) climbed 15.61 percent to close at $8.22. Oramed Pharma disclosed that its patent has been allowed in the US for oral administration of proteins.
    Dorian LPG Ltd. (NYSE: LPG) rose 14.89 percent to close at $8.41. Dorian LPG confirmed receipt of unsolicited proposal fr

Top Biotech Stocks To Own For 2019: Beasley Broadcast Group Inc.(BBGI)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Beasley Broadcast Group (NASDAQ:BBGI) Director Mark S. Fowler sold 5,505 shares of the company’s stock in a transaction dated Friday, May 18th. The stock was sold at an average price of $10.78, for a total value of $59,343.90. Following the sale, the director now owns 34,199 shares of the company’s stock, valued at $368,665.22. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Top Biotech Stocks To Own For 2019: Huntington Ingalls Industries, Inc.(HII)

Advisors’ Opinion:

  • [By Lou Whiteman]

    Huntington Ingalls Industries (NYSE:HII) and Lockheed Martin (NYSE:LMT)are each up about 25% over the past year, though Lockheed is significantly higher valued on both a price-to-earnings and price-to-sales basis. Let’s take a look at the prospects for both companies with an eye toward determining which is a better buy right now.

  • [By Lou Whiteman]

    More specifically, the budgeting process resulted in big wins relative to what the Pentagon requested for Lockheed Martin (NYSE:LMT), good news for Huntington Ingalls (NYSE:HII), and reason to hope that Textron (NYSE:TXT) can expand its military business.

  • [By Lou Whiteman]

    The bull case for shipbuilder Huntington Ingalls (NYSE:HII) is centered in no small part on the company’s place as the sole builder and maintainer of the nation’s fleet of nuclear-powered aircraft carriers. A reported shift in Navy thinking over the need for a massive carrier fleet could challenge Huntington’s growth expectations, though it’s too soon for investors to react to the speculation.

  • [By Rich Smith]

    Military shipbuilder Huntington Ingalls (NYSE:HII) beat its earnings estimates for the fourth quarter of 2018. In the report delivered earlier this month, it revealed that sales increased  10% year over year for both the quarter and the year as a whole. Profits more than tripled for the quarter, and were up a lower, but still staggering, 82.5% for the year — to $19.09 per diluted share.

  • [By Paul Ausick]

    The carriers are being constructed by Huntington Ingalls Industries Inc. (NYSE: HII) at a total acquisition cost of around $55 billion. Work on the carriers provides more than 20,000 jobs at Huntington’s Newport News shipyard.

  • [By Money Morning News Team]

    Huntington Ingalls Industries Inc. (NYSE: HII) is a major U.S. shipbuilding company that is involved in the design, construction, maintenance, and repair of both nuclear and non-nuclear vessels on behalf of the U.S. Navy and Coast Guard. It also refuels, overhauls, and deactivates nuclear-powered ships.

Leave a Reply

Your email address will not be published. Required fields are marked *